This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

LegitScript Shuts Down Rogue Internet Pharmacy "Mothership"

PORTLAND, Ore., Dec. 13, 2012 /PRNewswire/ -- Internet pharmacy monitoring and compliance firm LegitScript announced that it shut down, an Internet pharmacy affiliate marketing portal connected to hundreds of websites identified by drug safety regulators as selling unregulated prescription drugs without a prescription.

The firm states that it has shut down or disabled more than 15,000 rogue pharmacy websites in 2012, and about 30,000 since 2009.

The website was identified in an FDA warning letter earlier this year as "offering unapproved and misbranded drugs," by selling prescription drugs without a prescription, and unapproved drugs that had not been approved for safety and efficacy.

LegitScript President John Horton stated that was a key "anchor" website among hundreds in an online pharmacy network commonly known as "MyRxCash" where Internet marketers could download pre-designed online pharmacy templates, and set up multiple Internet pharmacies selling unapproved drugs and prescription-only medicines without a prescription online. According to LegitScript, affiliate marketers would then gain up to 40% commission on each illicit drug sale. "This website was like a proverbial 'mothership' that spawned hundreds of unlicensed, unregulated rogue online pharmacies selling prescription-only medicines to patients, thus putting their health and safety at risk," Horton said.

LegitScript's international Internet pharmacy standards are recognized by the National Association of Boards of Pharmacy, which represents pharmacy regulators in the US, Canada and other countries. The firm is endorsed by the NABP on the behalf of its regulatory boards as a resource for registrars and other Internet companies to verify the legitimacy, or lack thereof, of websites selling prescription drugs and other healthcare products.

LegitScript was also identified earlier this year by INTERPOL as assisting its efforts as part of Operation Pangea, a global effort focused on shuttering illicit online drug sellers.

Horton stated, "The name of the program itself, MyRxCash, underscores what these dangerous online pharmacies are really all about: profits, not patient safety." LegitScript's blog states that it had already shut down hundreds of MyRxCash's online pharmacies, and that LegitScript would continue targeting the network at the domain name and payment platform level.

LegitScript works with a variety of leading Internet platforms, including major search engines and e-commerce portals to ensure that the companies' platforms are not misused by rogue Internet pharmacies. Internet users can check online pharmacy legitimacy or report a rogue Internet pharmacy to LegitScript at

SOURCE LegitScript

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs